The main aim of the study is to describe the possible impacts of SARS-CoV-2 and itsvarious genotypes on pregnancy and long-term outcomes among pregnant women and theirnewborns in Estonia.
All the pregnant women in Estonia who conceived and gave birth between February 27, 2020,
and March 1, 2023 were included in the study. Pregnant women will be divided into 2
groups: 1. pregnant women who were diagnosed with COVID-19 during the study period, along
with their newborns; 2. control group: pregnant women who did not have COVID-19 during
pregnancy, along with their newborns. The following data is collected for each subject:
prior vaccination, previous COVID-19 infection, underlying diseases/conditions,
hospitalization, need for intensive care, need for mechanical ventilation and/or oxygen
therapy, death cases, post-COVID-19 symptoms, pregnancy course and outcomes, possible
virus transmission from mother to child, and the newborn's condition or accompanying
health issues
Other: COVID-19 infection
COVID-19 diagnosis in the health database
Inclusion Criteria:
- pregnancy (conceived and gave birth between February 27, 2020, and March 1, 2023)
with COVID-19 or without and their newborns
Exclusion Criteria:
- NA
University of Tartu
Tartu 588335, Estonia
Not Provided